Advertisement

Topics

Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for Patients with Pediatric-onset Hypophosphatasia (HPP)

04:00 EDT 5 Jul 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that it has reached a national funding agreement with the National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England based ...

Other Sources for this Article

Alexion:
Media
Kim Diamond, +1 475-230-3775
Executive Director, Corporate Communications
or
Lauren Cettier, +41 (0)44 457 4323
Director, External Communications, EMEA
or
Investors
Elena Ridloff, CFA, +1 475-230-3601
Vice President, Investor Relations
or
Catherine Hu, +1 475-230-3599
Director, Investor Relations

NEXT ARTICLE

More From BioPortfolio on "Alexion Reaches Funding Agreement with NICE and NHS England for Strensiq® (asfotase alfa) for Patients with Pediatric-onset Hypophosphatasia (HPP)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...